Enhance Diagnostics has been awarded a $25,000 prize from the American Academy of Pediatrics (AAP) Section on Advances in Therapeutics and Technology (SOATT) and the Southwest National Pediatric Device Innovation...
Fayetteville, AR—VIC Tech, a leading builder of high-impact, innovative life science companies, announces the formation of i-Seq Biotechnology, a portfolio company focused on advancing novel broad-spectrum vaccines and...
Can you share a bit about your career journey and what led you to your current roles at CU Innovations? How have your previous experiences shaped your approach to innovation and investment? My career journey has been a...
VIC Tech is pleased to announce the expansion of its Scientific Advisory Board (SAB) and Medical Advisory Board (MAB) with the addition of two esteemed experts. Dr. Alexandra H. Antonioli, MD, PhD, joins the MAB, and...
VIC Foundry is proud to announce that it has been awarded a Small Business Innovation Research (SBIR) grant from the National Institute of Dental and Craniofacial Research (NIDCR) to support the commercialization of its...
FAYETTEVILLE, AR- VIC Tech is pleased to announce Paige Jernigan's appointment to its Board of Directors. Jernigan brings a wealth of experience in equity analysis, fundraising, and advisory services, with a career that...
The VIC Tech investment model is unique, sourcing promising life science innovations directly from universities nationwide. It provides funding to launch startup companies and advance these technologies, ultimately...
Funding Led by Tramway Venture Partners Includes Key Appointments to the Board and Accelerates the Development of High-Dose Lung Delivery Solutions. Nob Hill Therapeutics (NHT), an early-stage pulmonary medical device...
The Defense Health Agency (DHA)—an important component of the United States Military Health System—has selected Solaris Vaccines to create a safe and effective vaccine for preventing death and disease caused by the...
Our mid-year update showcases a remarkable first half of 2024, with substantial product development and commercialization progress, new private investments, and key advancements in FDA clearance.
FEATURED RESOURCES
